Industry Tries To Nix OTC State Regulations
The derivatives industry is lobbying members of Congress to include provisions in the proposed federal derivative laws that would pre-empt any similar state legislation.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
